Cyclo Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Cyclo Therapeutics has a total shareholder equity of $4.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $13.2M and $8.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.25m |
| Equity | US$4.76m |
| Total liabilities | US$8.49m |
| Total assets | US$13.25m |
Recent financial health updates
Here's Why We're A Bit Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Situation
Jul 12
We're A Little Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jan 20Will Cyclo Therapeutics (NASDAQ:CYTH) Spend Its Cash Wisely?
Sep 28We're Keeping An Eye On Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jun 12Recent updates
Cyclo Therapeutics GAAP EPS of -$0.41 beats by $0.12, revenue of $0.54M misses by $0.08M
Aug 16Here's Why We're A Bit Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Situation
Jul 12We're A Little Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jan 20Cyclo Therapeutics: Addressing The Fundamentals Of Alzheimer's Disease
Nov 16Will Cyclo Therapeutics (NASDAQ:CYTH) Spend Its Cash Wisely?
Sep 28Cyclo therapeutics to join Russell 2000 Index
Jun 14We're Keeping An Eye On Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jun 12Cyclo Therapeutics posts design protocol of pivotal late-stage study of Trappsol Cyclo
Apr 27Cyclo Therapeutics' lead candidate shows durable benefit in Niemann-Pick Disease
Jan 05How Much Is Cyclo Therapeutics, Inc. (NASDAQ:CYTH) CEO Getting Paid?
Dec 12Financial Position Analysis
Short Term Liabilities: CYTH's short term assets ($12.3M) exceed its short term liabilities ($8.5M).
Long Term Liabilities: CYTH's short term assets ($12.3M) exceed its long term liabilities ($22.5K).
Debt to Equity History and Analysis
Debt Level: CYTH is debt free.
Reducing Debt: CYTH had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYTH has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CYTH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.3% each year